Fisher & Paykel Healthcare achieves record revenue, profit soars

Fisher & Paykel Healthcare (NZX:FPH) reported a record total operating revenue of NZD 2.02 billion for the financial year ended March 31, 2025, a 16% increase from the prior year. Net profit after tax surged to NZD 377.2 million, a 43% increase year-over-year. The Hospital product group saw revenue climb 18% to NZD 1.28 billion, while the Homecare product group revenue increased 13% to NZD 739.9 million. The company invested NZD 226.9 million in research and development during the year and plans capital expenditure of approximately NZD 225 million for the 2026 financial year. A final dividend of 24.0 cents per share was declared, bringing the total dividend for the year to 42.5 cents per share. The company projects full year operating revenue for 2026 to be in the range of approximately NZD 2.15 billion to NZD 2.25 billion and net profit after tax to be in the range of approximately NZD 390 million to NZD 440 million.